Delivery Order SPE2DB24D1021-SPE2DB26FERHX
Award Date 10/16/25
Potential Completion Date 10/17/25
Potential Value $32K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,370.39 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation. The award represents a single delivery transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a $3,879.96 delivery order to AmerisourceBergen Drug Corp for Vaxneuvance 0.5 ML syringes, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order carries no set-aside designation and will...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,358.35 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion pharmaceutical supply vehicle that runs through December 2026. The delivery order is scheduled for completion by July 28, 2025, with performance...
- The Defense Logistics Agency awarded a delivery order valued at $17,442.92 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 ML syringes. This firm fixed-price contract, issued on May 19, 2025, with an ultimate completion date of May 20, 2025, represents a competitively awarded non-set-aside procurement. The products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and distribution operations. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes valued at $1,370.34 on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price contract represents a non-competitive set-aside and will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,000.54 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 ML syringes on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vaxneuvance is a pneumococcal vaccine product, reflecting the critical role AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,301.55 to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Vaxneuvance 0.5 ML syringes. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,740.70 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on August 19, 2025, with an ultimate completion date of August 20, 2025. This contract utilized firm fixed price pricing and was competitively awarded without any set-aside designation. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $58,226.32 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes. This firm fixed-price contract, issued on July 31, 2025, represents a non-set-aside award made through open competition. The work will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,970.66 on April 21, 2025, for the supply of Vaxneuvance 0.5 mL syringes. This firm fixed-price, competitively awarded contract represents a non-set-aside procurement with an ultimate completion date of April 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite...